These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26241532)

  • 1. The role of diffusion weighted MR imaging for differentiation between Graves' disease and Hashimoto thyroiditis.
    Ozturk T; Bozgeyik Z; Ozturk F; Burakgazi G; Akyol M; Coskun S; Ozkan Y; Ogur E
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2798-803. PubMed ID: 26241532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases.
    Mukasa K; Noh JY; Kunii Y; Matsumoto M; Sato S; Yasuda S; Suzuki M; Ito K; Ito K
    Thyroid; 2011 Jan; 21(1):37-41. PubMed ID: 20932180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of shear wave elastography by virtual touch tissue imaging quantification in patients with diffuse thyroid gland pathology.
    Kural Rahatlı F; Turnaoğlu H; Kırnap NG; Turhan İyidir Ö; Haberal KM; Soudman A; Uslu N
    Turk J Med Sci; 2018 Oct; 48(5):993-998. PubMed ID: 30384566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic role of thyroid elastography in pediatric patients with Hashimoto's thyroiditis and Graves' disease: A prospective controlled study.
    Bitkin EC; Toprak N
    Arch Pediatr; 2023 Feb; 30(2):104-108. PubMed ID: 36509627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hashimoto's thyroiditis following Graves' disease.
    Umar H; Muallima N; Adam JM; Sanusi H
    Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighed MR of the thyroid gland in Graves' disease: assessment of disease activity and prediction of outcome.
    Abdel Razek AA; Sadek AG; Gaballa G
    Acad Radiol; 2010 Jun; 17(6):779-83. PubMed ID: 20350826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four cases of Graves' disease which developed after painful Hashimoto's thyroiditis.
    Ohye H; Nishihara E; Sasaki I; Kubota S; Fukata S; Amino N; Kuma K; Miyauchi A
    Intern Med; 2006; 45(6):385-9. PubMed ID: 16617190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Digit Ratio (2D:4D) Be Indicative of Predispositions to Autoimmune Thyroid Diseases in Women - Hashimoto Thyroiditis and Graves' Disease?
    Święchowicz B; Kasielska-Trojan A; Manning JT; Antoszewski B
    Front Endocrinol (Lausanne); 2022; 13():914471. PubMed ID: 35846322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graves' disease associated with alopecia areata developing after Hashimoto's thyroiditis.
    Aşık M; Binnetoğlu E; Şen H; Tekeli Z; Uysal F; Ukinç K
    J Nippon Med Sch; 2013; 80(6):467-9. PubMed ID: 24419720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Diffusion-Weighted Magnetic Resonance (MR) Imaging in Differentiation Between Graves' Disease and Painless Thyroiditis.
    Abdel Razek AAK; Abd Allah SS; El-Said AAE
    Pol J Radiol; 2017; 82():536-541. PubMed ID: 29662585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' disease following hypothyroidism due to Hashimoto's thyroiditis in a black South African lady: a case report.
    Ekpebegh C; Elmezughi K; Mtingi L
    Pan Afr Med J; 2019; 32():186. PubMed ID: 31312298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid Ultrasonography in Differentiation between Graves' Disease and Hashimoto's Thyroiditis.
    Pishdad P; Pishdad GR; Tavanaa S; Pishdad R; Jalli R
    J Biomed Phys Eng; 2017 Mar; 7(1):21-26. PubMed ID: 28451576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of the thyroid: correlation between apparent diffusion coefficient and thyroid gland scintigraphy.
    Tezuka M; Murata Y; Ishida R; Ohashi I; Hirata Y; Shibuya H
    J Magn Reson Imaging; 2003 Feb; 17(2):163-9. PubMed ID: 12541222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
    Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hashimoto's thyroiditis presenting as Graves-Basedow disease.
    Mollar Puchades MA; Merino Torres JF; Pérez Lázaro MA; Segovia Portolés R; Abellán Galiana P; Piñón Sellés F
    Thyroid; 2007 Nov; 17(11):1151-2. PubMed ID: 17822375
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis.
    Vitti P; Rago T; Mazzeo S; Brogioni S; Lampis M; De Liperi A; Bartolozzi C; Pinchera A; Martino E
    J Endocrinol Invest; 1995 Dec; 18(11):857-61. PubMed ID: 8778158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of Coexistence of Hashimoto Thyroiditis and Graves' Disease with Differentiated and Medullary Thyroid Cancer.
    Machens A; Lorenz K; Weber F; Dralle H
    Exp Clin Endocrinol Diabetes; 2022 Jun; 130(6):381-385. PubMed ID: 34517418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-establishment of normal radioactive iodine uptake reference range in the era of universal salt iodization in the Indian population.
    Ballal S; Soundararajan R; Bal C
    Indian J Med Res; 2017 Mar; 145(3):358-364. PubMed ID: 28749399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
    Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation and validation of the Hungarian version of Thyroid-Related Patient-Reported Outcome-39 (ThyPro-39) questionnaire: testing factor structure, known-group validity with the comparison of quality of life in Hashimoto's thyroiditis and Graves' disease.
    Rigó A; Malkov K; Szabó A; Bognár VK; Urbán R
    J Patient Rep Outcomes; 2023 Jun; 7(1):60. PubMed ID: 37368126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.